Nasal spray to prevent ear fluid after radiation for nasal cancer
Treatments studied
Part of Ear, nose & throat, Injuries & trauma clinical trials.
This trial tests if a corticosteroid nasal spray can prevent fluid buildup in the ear, a common side effect of radiation therapy for nasopharyngeal carcinoma. It's for patients who are about to start radiation and have not had ear surgery or previous head and neck radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with nasopharyngeal cancer and are scheduled for radiation therapy.
- You are between 18 and 75 years old.
- You have not had radiation to your head or neck before.
- Both eardrums are intact and you have not had ear surgery.
- You have not used steroid sprays, antihistamines, or decongestants in the last 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often radiation therapy for throat cancer causes middle ear infections or fluid buildup. It aims to understand and track these ear problems in patients getting a precise type of radiation called IMRT.
This trial tests whether giving a lower dose of radiation to the main tumor is safe and effective for people with nasopharyngeal cancer (a type of nose/throat cancer) who first receive a combination of immunotherapy (toripalimab) and chemotherapy. It aims to reduce side effects while still controlling the cancer.
This trial tests whether a new form of steroid (triamcinolone) delivered in tiny capsules can improve healing after common nasal surgeries for chronic sinusitis or nasal polyps.
This trial tests a new way to shape the radiation field for nasopharyngeal cancer that has spread into the nasal cavity. The goal is to reduce radiation to the nose while still effectively treating the cancer.
This trial tests if lowering the radiation dose and area for the neck can be as effective as standard treatment for nasopharyngeal cancer. It aims to reduce side effects while still controlling the disease.
This trial tests a new type of radiation therapy that adjusts in real-time to treat nasopharyngeal cancer. It is for people who have not received prior radiation and have no distant spread of cancer.
Hear when a new Otitis Media trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.